A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis
LR Solomon, JS Cheesbrough, L Ebah… - American Journal of …, 2010 - Elsevier
BACKGROUND: Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
LR Solomon, JS Cheesbrough, L Ebah… - American Journal of …, 2010 - pure.johnshopkins.edu
Background: Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
LR Solomon, JS Cheesbrough, L Ebah… - American Journal of …, 2010 - ajkd.org
Background Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
LR Solomon, JS Cheesbrough, L Ebah… - American Journal of …, 2010 - europepmc.org
Background Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis
LR Solomon, JS Cheesbrough, L Ebah, T Al-Sayed… - 2010 - pubmed.ncbi.nlm.nih.gov
Background Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
L Solomon, J Cheeseborough… - … Journal of Kidney …, 2010 - escholar.manchester.ac.uk
Background: Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
[引用][C] A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
LR SOLOMON, JS CHEESBROUGH… - American journal of …, 2010 - pascal-francis.inist.fr
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the
Prevention of Bacteremia in Patients Treated With Hemodialysis CNRS Inist Pascal-Francis CNRS …
Prevention of Bacteremia in Patients Treated With Hemodialysis CNRS Inist Pascal-Francis CNRS …
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis
LR Solomon, JS Cheesbrough… - … Journal of Kidney …, 2010 - research.manchester.ac.uk
BACKGROUND: Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
LR Solomon, JS Cheesbrough, L Ebah, T Al-Sayed… - 2010 - cabidigitallibrary.org
Background-Bacteremia is a major cause of morbidity in patients using intravascular
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
catheters. Interdialytic locking with antibiotics decreases the incidence of bacteremia, but …
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
LR Solomon, JS Cheesbrough, L Ebah… - American Journal of …, 2010 - infona.pl
Bacteremia is a major cause of morbidity in patients using intravascular catheters.
Interdialytic locking with antibiotics decreases the incidence of bacteremia, but risks …
Interdialytic locking with antibiotics decreases the incidence of bacteremia, but risks …